Any changes to law on human gene editing should be after public consultation
By Peter McKnight,
Vancouver Sun
| 12. 08. 2022
When a scientist announces the opening of a new laboratory, it doesn’t ordinarily make news around the world. But Chinese biophysicist He Jiankui is no ordinary scientist.
He’s announcement at the end of November came just seven months after he completed a three-year prison sentence for practising medicine illegally. At issue was He’s 2018 YouTube announcement that he had created the world’s first gene-edited babies.
As details became clear, scientists and lawmakers inside and outside China condemned He’s actions, and he was ultimately fired, fined and sentenced to prison. Gene editing also received a lot of negative press, with the usual stories about designer babies flooding the media. He’s new announcement could result in a repeat of the hysteria.
Indeed, stories raising the spectre of eugenics led Canada to prohibit human gene editing long before He created his designer babies. He employed a technique known as CRISPR, short for clustered regularly interspaced short palindromic repeats, which acts like a pair of scissors that allows scientists to edit parts of the human genome.
He used CRISPR to edit the genes of...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...